About 4 million people in the US are estimated to have hepatitis C antibodies (evidence of prior infection).

Sixty percent or more of patients are unaware of their infections.

HCV may now be responsible for 15-20% of new acute hepatitis cases and half of the cases of liver cancer occuring in the US.